A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
Clinical trial NCT07271251 · COMPLETED
Trial details
- NCT number
- NCT07271251
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-06-29
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.